From October 1, 2014 to December 31, 2014, the company has repurchased 775,897 shares, representing 0.54% for $50 million. With this, the company has completed the repurchase of 40,358,727 shares, representing 25.24% for $2,307.47 million under the buyback announced on October 20, 2010.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,498 GBX | -1.25% |
|
-0.76% | +3.30% |
15/07 | Second malaria vaccine launched in Ivory Coast in new milestone | RE |
15/07 | GSK: ViiH Healthcare to present its advances in HIV | CF |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.30% | 79.32B | |
+63.05% | 856B | |
+39.42% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+14.19% | 244B | |
+5.81% | 234B | |
+16.77% | 226B | |
+14.63% | 177B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010.